Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.

Dubai, United Arab Emirates
Aster DM Healthcare offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 1987, the JCI, NABH, NABL hospital is located in Dubai, United Arab Emirates and has 114 beds, providing comprehensive care for local and international patients.
CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.
Medipol Bahçelievler Hospital provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2022, the JCI hospital is located in Istanbul, Turkey, and operates 441 beds, equipped with modern healthcare infrastructure.
CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.
Medanta - The Medicity offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2009, the JCI, NABH hospital is located in Gurgaon, India and has 1250 beds, providing comprehensive care for local and international patients.
CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.
Sharjah, United Arab Emirates
Choosing NMC Royal Hospital Sharjah for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 1981, the JCI hospital in Sharjah, United Arab Emirates has 137 beds and provides specialised cardiac services.
CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.
At Phyathai 2 International Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 1987, this JCI hospital in Bangkok, Thailand has 550 beds and provides comprehensive cardiovascular care.
CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.
ParkCity Medical Centre is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2012, the JCI hospital is situated in Kuala Lumpur, Malaysia and has 300 beds.
CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.
Choosing Florence Nightingale Hospital for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 1989, the JCI hospital in Istanbul, Turkey has 804 beds and provides specialised cardiac services.
CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.
Parkway East Hospital is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1942, the JCI hospital is situated in Singapore, Singapore and has 143 beds.
CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.
At Krabi Nakharin International Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 1997, this JCI hospital in Krabi, Thailand has 150 beds and provides comprehensive cardiovascular care.
CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.
Choosing Gleneagles Hospital Mumbai for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 1996, the JCI hospital in Mumbai, India has 450 beds and provides specialised cardiac services.
CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.
Subang Jaya Medical Centre offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 1985, the JCI hospital is located in Kuala Lumpur, Malaysia and has 442 beds, providing comprehensive care for local and international patients.
CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.
Saudi German Hospital offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2012, the JCI hospital is located in Dubai, United Arab Emirates and has 300 beds, providing comprehensive care for local and international patients.
CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.
Yanhee International Hospital is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1984, the ISO, JCI hospital is situated in Bangkok, Thailand and has 400 beds.
CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.
Antalya Anadolu Hastanesi offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2006, the hospital is located in Antalya, Turkey and has 114 beds, providing comprehensive care for local and international patients.
CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.
Ghaziabad, India
Max Super Specialty Hospital, Vaishali offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2008, the NABL, NABH hospital is located in Ghaziabad, India and has 370 beds, providing comprehensive care for local and international patients.
CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.

Cardiac resynchronization therapy (CRT) has revolutionized the management of heart failure, particularly in patients with conduction delays and dysynchrony of ventricular contraction.